1. Biyobenzer İlaçlar
    Çağla KÜÇÜK et al, 2021, Beykent Üniversitesi Fen ve Mühendislik Bilimleri Dergisi CrossRef
  2. The Impact of Introducing Successive Biosimilars on Changes in Prices of Adalimumab, Infliximab, and Trastuzumab—Polish Experiences
    Olga Barszczewska et al, 2021, International Journal of Environmental Research and Public Health CrossRef
  3. Changes in the Penetration Rate of Biosimilar Infliximab Within Japan Using a Japanese Claims Database
    Tsugumi Matsumoto et al, 2021, ClinicoEconomics and Outcomes Research CrossRef
  4. Nurses’ Knowledge and Attitudes towards Biosimilar Medicines as Part of Evidence-Based Nursing Practice—International Pilot Study within the Project Biosimilars Nurses Guide Version 2.0
    Adriano Friganović et al, 2022, International Journal of Environmental Research and Public Health CrossRef